Logo image of CLMT

CALUMET INC (CLMT) Stock Fundamental Analysis

USA - NASDAQ:CLMT - US1314281049 - Common Stock

18.19 USD
-0.76 (-4.01%)
Last: 10/17/2025, 5:20:01 PM
18.31 USD
+0.12 (+0.66%)
After Hours: 10/17/2025, 5:20:01 PM
Fundamental Rating

1

CLMT gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 211 industry peers in the Oil, Gas & Consumable Fuels industry. CLMT has a bad profitability rating. Also its financial health evaluation is rather negative. CLMT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CLMT had negative earnings in the past year.
CLMT had a negative operating cash flow in the past year.
In the past 5 years CLMT reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: CLMT reported negative operating cash flow in multiple years.
CLMT Yearly Net Income VS EBIT VS OCF VS FCFCLMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

Looking at the Return On Assets, with a value of -16.25%, CLMT is doing worse than 89.57% of the companies in the same industry.
Industry RankSector Rank
ROA -16.25%
ROE N/A
ROIC N/A
ROA(3y)-4.08%
ROA(5y)-6.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CLMT Yearly ROA, ROE, ROICCLMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

1.3 Margins

In the last couple of years the Operating Margin of CLMT has declined.
CLMT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5Y-41.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CLMT Yearly Profit, Operating, Gross MarginsCLMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

More info and screens

0

2. Health

2.1 Basic Checks

CLMT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CLMT has been increased compared to 1 year ago.
The number of shares outstanding for CLMT has been increased compared to 5 years ago.
The debt/assets ratio for CLMT is higher compared to a year ago.
CLMT Yearly Shares OutstandingCLMT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CLMT Yearly Total Debt VS Total AssetsCLMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

Based on the Altman-Z score of 0.38, we must say that CLMT is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.38, CLMT is not doing good in the industry: 64.93% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.38
ROIC/WACCN/A
WACC10.21%
CLMT Yearly LT Debt VS Equity VS FCFCLMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 0.76 indicates that CLMT may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.76, CLMT is doing worse than 71.09% of the companies in the same industry.
CLMT has a Quick Ratio of 0.76. This is a bad value and indicates that CLMT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.45, CLMT is doing worse than 87.20% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.45
CLMT Yearly Current Assets VS Current LiabilitesCLMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

3

3. Growth

3.1 Past

CLMT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1756.25%.
CLMT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -22.79%.
CLMT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.94% yearly.
EPS 1Y (TTM)-1756.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-254.17%
Revenue 1Y (TTM)-22.79%
Revenue growth 3Y9.99%
Revenue growth 5Y3.94%
Sales Q2Q%-9.45%

3.2 Future

CLMT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.17% yearly.
The Revenue is expected to grow by 7.25% on average over the next years.
EPS Next Y-67.84%
EPS Next 2Y33.24%
EPS Next 3Y24.72%
EPS Next 5Y29.17%
Revenue Next Year1.05%
Revenue Next 2Y2.04%
Revenue Next 3Y7.23%
Revenue Next 5Y7.25%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CLMT Yearly Revenue VS EstimatesCLMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B
CLMT Yearly EPS VS EstimatesCLMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 -4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CLMT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CLMT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CLMT Price Earnings VS Forward Price EarningsCLMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 -30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CLMT Per share dataCLMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

A more expensive valuation may be justified as CLMT's earnings are expected to grow with 24.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.24%
EPS Next 3Y24.72%

More info and screens

0

5. Dividend

5.1 Amount

CLMT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CALUMET INC

NASDAQ:CLMT (10/17/2025, 5:20:01 PM)

After market: 18.31 +0.12 (+0.66%)

18.19

-0.76 (-4.01%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-08 2025-08-08/bmo
Earnings (Next)11-07 2025-11-07
Inst Owners51.5%
Inst Owner Change0.1%
Ins Owners2.93%
Ins Owner Change-1.79%
Market Cap1.58B
Analysts78.33
Price Target20.46 (12.48%)
Short Float %13.38%
Short Ratio10.43
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-377.07%
Min EPS beat(2)-407.62%
Max EPS beat(2)-346.52%
EPS beat(4)1
Avg EPS beat(4)-194.87%
Min EPS beat(4)-407.62%
Max EPS beat(4)30.36%
EPS beat(8)4
Avg EPS beat(8)85.48%
EPS beat(12)5
Avg EPS beat(12)-504.19%
EPS beat(16)6
Avg EPS beat(16)-374.79%
Revenue beat(2)2
Avg Revenue beat(2)9.05%
Min Revenue beat(2)8.78%
Max Revenue beat(2)9.31%
Revenue beat(4)4
Avg Revenue beat(4)7.51%
Min Revenue beat(4)0.99%
Max Revenue beat(4)10.98%
Revenue beat(8)8
Avg Revenue beat(8)8.83%
Revenue beat(12)11
Avg Revenue beat(12)8.29%
Revenue beat(16)15
Avg Revenue beat(16)10.55%
PT rev (1m)0%
PT rev (3m)0.31%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-50.8%
EPS NY rev (1m)-6.67%
EPS NY rev (3m)-91.16%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)7.12%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.96%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.39
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-5.94
EYN/A
EPS(NY)-0.59
Fwd EYN/A
FCF(TTM)-2.3
FCFYN/A
OCF(TTM)-1.46
OCFYN/A
SpS46.92
BVpS-11.64
TBVpS-11.64
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.25%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.08%
ROA(5y)-6.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.9%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-41.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.47
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 48.93%
Cap/Sales 1.79%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.76
Quick Ratio 0.45
Altman-Z 0.38
F-Score2
WACC10.21%
ROIC/WACCN/A
Cap/Depr(3y)260.7%
Cap/Depr(5y)180.19%
Cap/Sales(3y)6.59%
Cap/Sales(5y)4.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1756.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-254.17%
EPS Next Y-67.84%
EPS Next 2Y33.24%
EPS Next 3Y24.72%
EPS Next 5Y29.17%
Revenue 1Y (TTM)-22.79%
Revenue growth 3Y9.99%
Revenue growth 5Y3.94%
Sales Q2Q%-9.45%
Revenue Next Year1.05%
Revenue Next 2Y2.04%
Revenue Next 3Y7.23%
Revenue Next 5Y7.25%
EBIT growth 1Y-186.36%
EBIT growth 3YN/A
EBIT growth 5Y-39.24%
EBIT Next Year2694.27%
EBIT Next 3Y276.96%
EBIT Next 5Y146.58%
FCF growth 1Y66.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-227.06%
OCF growth 3YN/A
OCF growth 5YN/A